First Stage of Clinical Testing Complete
ZSX completes the first stage of ZIMS, the U.S. clinical study using Zip-stitch, with the 10th Zip-stitch case successfully completing 6-week follow-up. "This is a tremendous milestone for ZSX Medical, and it represents an important step forward in women's health, creating an opportunity to reduce the number of women who have to undergo invasive large-incision hysterectomy," says President and CEO Dan Mazzucco. The company will now work to obtain further funding to complete its clinical development and bring Zip-stitch to market.
ZSX Bolsters Board of Managers
ZSX Medical is pleased to announce the addition of Audrey Greenberg and Kathleen Brunner to our board, extending the breadth and depth of our Team's relevant expertise.
FDA Gives IDE Approval for ZIMS Study
FDA has granted approval for us to begin our pivotal clinical study to evaluate the safety and efficacy of Zip-stitch.
What is ZSX Medical?
ZSX Medical, LLC, is a clinical-stage medical device company improving minimally-invasive surgery. We are developing Zip-stitch, a surgical closure system that is designed to make difficult surgical closures fast and easy for physicians, saving money for hospitals and improving outcomes for patients.